Table 5.
Results of ALK testing in selected centers in 2014a
| ALK, n (%) | Non-diagnostic | ||
|---|---|---|---|
| WT | Rearrangement | ||
| Croatia | 161 (93.1) | 12 (6.9) | 28 |
| Czech (Prague) | 55 (96.5) | 2 (3.5) | 10 |
| Czech (Hradec Kralove) | 260 (95.2) | 13 (4.8) | 2 |
| Hungary (Budapest, Timár) | 332 (94.9) | 18 (5.1) | 0 |
| Hungary (Budapest, Toth) | 122 (98.4) | 2 (1.6) | 4 |
| Hungary (Budapest, Kovalszky) | 415 (95.6) | 19 (4.4) | 0 |
| Hungary (Debrecen) | 226 (91.5) | 21 (8.5) | 35 |
| Hungary (Pécs) | 55 (94.8) | 3 (5.2) | 2 |
| Slovakia | 375 (88) | 51 (12) | 0 |
| Slovenia | 199 (96.5) | 7 (3.5) | 0 |
| Turkey (Cerrahpaşa) | 764 (95.6) | 35 (4.4) | 14 |
ALK anaplastic lymphoma kinase, WT wild-type
aNote that these numbers cannot be compared directly because of the different criteria for selection of samples to test; in some centers only samples negative for KRAS and EGFR mutations were tested for ALK translocations